Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study,Movement Disorders

当前位置： X-MOL 学术 › Mov. Disord. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study
Movement Disorders ( IF 7.4 ) Pub Date : 2021-09-08 , DOI: 10.1002/mds.28758
Werner Poewe ₁ , Fabrizio Stocchi ₂ , David Arkadir ₃ , Georg Ebersbach ₄ , Aaron L Ellenbogen ₅ , Nir Giladi ₆ , Stuart H Isaacson ₇ , Karl Kieburtz ₈ , Peter LeWitt ₉ , C Warren Olanow ₈ , Tanya Simuni ₁₀ , Astrid Thomas ₁₁ , Abraham Zlotogorski ₁₂ , Liat Adar ₁₃ , Ryan Case ₁₃ , Sheila Oren ₁₃ , Shir Fuchs Orenbach ₁₃ , Olivia Rosenfeld ₁₃ , Nissim Sasson ₁₃ , Tami Yardeni ₁₃ , Alberto J Espay ₁₄ ,

Affiliation

Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
University and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.
Department of Neurology, The Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Movement Disorder Clinic, Beelitz-Heilstaetten, Beelitz, Germany.
Michigan Institute for Neurological Disorders, Farmington Hills, Michigan, USA.
Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Neurosciences, Neurological Institute, Tel-Aviv University, Tel Aviv, Israel.
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, USA.
Departments of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, Detroit, Michigan, USA.
Clintrex Research Corp, Sarasota, Florida, USA.
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Neuroscience, Imaging and Clinical Sciences and Center of Advanced Studies and Technology CAST, University Chieti Pescara, Chieti, Italy.
Department of Dermatology, The Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
NeuroDerm Ltd, Rehovot, Israel.
James J. and Joan A. Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio, USA.

Continuous, subcutaneous (SC) levodopa/carbidopa infusion with ND0612 is under development as a treatment for patients with Parkinson's disease (PD) and motor fluctuations.

中文翻译：